Biosimilar Newsletter Archive

31. 09.20.21 -- Controlling Your Process From Idea To Injection 9/20/2021

    09/20/21 Biosimilar Development Newsletter

32. 09.16.21 -- The 5-Step Checklist For A More Mature, Robust Quality Management System 9/16/2021
    09/16/21 Biosimilar Development Newsletter
33. 09.14.21 -- Five Companies' Perspectives On Developing Cell And Gene Therapies 9/14/2021

    09/14/21 Biosimilar Development Newsletter

34. 09.09.21 -- Prefilled Syringes: Using X-Ray Analysis To Assess Container Closure Integrity 9/9/2021
    09/09/21 Biosimilar Development Newsletter
35. 09.08.21 -- New Podcast Episodes: GMP Meets RNA Cell Therapies, Cold Chain Sustainability, and more. 9/8/2021
    09/08/21 Biosimilar Development Newsletter
36. 09.03.21 -- Pursuing Drug Delivery Excellence: Overcoming Challenges Of Biologics 9/3/2021

    09/03/21 Biosimilar Development Newsletter

37. 09.02.21 -- Got Microorganisms? Determining Risk To Your Drug Product 9/2/2021
    09/02/21 Biosimilar Development Newsletter
38. 08.29.21 -- Is The Legislative Intent Of The BPCIA In Danger? 8/29/2021
    08/29/21 Biosimilar Development Newsletter
39. 08.26.21 -- Is The Legislative Intent Of The BPCIA In Danger? 8/26/2021
    08/26/21 Biosimilar Development Newsletter
40. 08.23.21 -- Continuous And Process Intensification Strategies To Maximize Productivity And Efficiency 8/23/2021

    08/23/21 Biosimilar Development Newsletter